Alkermes’ Corporate Presentation to be Webcast at the 34th Annual J.P. Morgan Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2016, at 9:00 a.m. PST (12:00 p.m. EST/5:00 p.m. GMT) from the Westin St. Francis Hotel in San Francisco. The presentation will be followed by a question and answer session that will begin at 9:30 a.m. PST (12:30 p.m. EST/5:30 p.m. GMT). A webcast of both the presentation and question and answer session may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160105006622/en/

Alkermes plcEva Stroynowski, [phone]Corporate Communications